Afterward, we compared the level changes of several interleukins (IL-1β, IL-6, IL-8, and IL-10) from pre-treatment to post-effective OSA treatments in patients with OSA. The gene discussed is CXCL8; the disease is obstructive sleep apnea syndrome.